quinacrine has been researched along with Myoclonic Jerk in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinacrine at 300 mg/day was given enterally for 3 months." | 2.71 | Results of quinacrine administration to patients with Creutzfeldt-Jakob disease. ( Furukawa, H; Kataoka, Y; Kusuhara, T; Nakajima, M; Takahashi, M; Yamada, T; Yamauchi, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, M | 1 |
| Yamada, T | 1 |
| Kusuhara, T | 1 |
| Furukawa, H | 1 |
| Takahashi, M | 1 |
| Yamauchi, A | 1 |
| Kataoka, Y | 1 |
| Beaumanoir, A | 1 |
| Martin, F | 1 |
2 trials available for quinacrine and Myoclonic Jerk
| Article | Year |
|---|---|
Results of quinacrine administration to patients with Creutzfeldt-Jakob disease.
Topics: Antimalarials; Creutzfeldt-Jakob Syndrome; Electroencephalography; Eye Movements; Female; Head Movem | 2004 |
[Therapy of generalized epilepsies using Acrisuxine].
Topics: Behavior; Child; Clinical Trials as Topic; Electroencephalography; Epilepsy, Absence; Epilepsy, Toni | 1969 |